These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22883137)

  • 1. CASE plots for the chemotype-based activity and selectivity analysis: a CASE study of cyclooxygenase inhibitors.
    Pérez-Villanueva J; Medina-Franco JL; Méndez-Lucio O; Yoo J; Soria-Arteche O; Izquierdo T; Lozada MC; Castillo R
    Chem Biol Drug Des; 2012 Nov; 80(5):752-62. PubMed ID: 22883137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: use of genetic function approximation.
    Zambre AP; Ganure AL; Shinde DB; Kulkarni VM
    J Chem Inf Model; 2007; 47(2):635-43. PubMed ID: 17256838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Najafnia L; Daraee B; Dadrass OG; Hedayati M
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5634-7. PubMed ID: 17822894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-1 and cyclooxygenase-2 inhibition of novel 1,2-disubstituted imidazoles.
    Handler N; Jaeger W; Kuen-Krismer B; Erker T
    Arch Pharm (Weinheim); 2005 Dec; 338(12):602-4. PubMed ID: 16353278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partially unified multiple property recursive partitioning (PUMP-RP) analyses of cyclooxygenase (COX) inhibitors.
    Rao SN; Stockfisch TP
    J Chem Inf Comput Sci; 2003; 43(5):1614-22. PubMed ID: 14502496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole based cyclooxygenase inhibitors: synthesis, biological evaluation, docking and NMR screening.
    Estevão MS; Carvalho LC; Freitas M; Gomes A; Viegas A; Manso J; Erhardt S; Fernandes E; Cabrita EJ; Marques MM
    Eur J Med Chem; 2012 Aug; 54():823-33. PubMed ID: 22796043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hierarchical strategy for identifying active chemotype classes in compound databases.
    Medina-Franco JL; Petit J; Maggiora GM
    Chem Biol Drug Des; 2006 Jun; 67(6):395-408. PubMed ID: 16882314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diarylheterocycle core ring features effect in selective COX-1 inhibition.
    Perrone MG; Vitale P; Malerba P; Altomare A; Rizzi R; Lavecchia A; Di Giovanni C; Novellino E; Scilimati A
    ChemMedChem; 2012 Apr; 7(4):629-41. PubMed ID: 22278975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of novel N-phenylnicotinamides as selective cyclooxygenase-1 inhibitors.
    Shi L; Li ZL; Yang Y; Zhu ZW; Zhu HL
    Bioorg Med Chem Lett; 2011 Jan; 21(1):121-4. PubMed ID: 21144750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses and characterization of nimesulide derivatives for dual enzyme inhibitors of both cyclooxygenase-1/2 and 5-lipoxygenase.
    Li Y; Chen SH; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
    Bioorg Med Chem; 2011 Mar; 19(6):2074-83. PubMed ID: 21349729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors.
    Eleftheriou P; Geronikaki A; Hadjipavlou-Litina D; Vicini P; Filz O; Filimonov D; Poroikov V; Chaudhaery SS; Roy KK; Saxena AK
    Eur J Med Chem; 2012 Jan; 47(1):111-24. PubMed ID: 22119153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of new 1,3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Zebardast T; Daraie B; Hedayati M
    Bioorg Med Chem; 2009 Aug; 17(15):5369-73. PubMed ID: 19596198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation.
    Schühly W; Hüfner A; Pferschy-Wenzig EM; Prettner E; Adams M; Bodensieck A; Kunert O; Oluwemimo A; Haslinger E; Bauer R
    Bioorg Med Chem; 2009 Jul; 17(13):4459-65. PubMed ID: 19481465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production.
    Chen CS; Tan CM; Huang CH; Chang LC; Wang JP; Cheng FC; Chern JW
    Bioorg Med Chem; 2010 Jan; 18(2):597-604. PubMed ID: 20056549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atropisomerism observed in indometacin derivatives.
    Takahashi H; Wakamatsu S; Tabata H; Oshitari T; Harada A; Inoue K; Natsugari H
    Org Lett; 2011 Feb; 13(4):760-3. PubMed ID: 21250752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and screening of cyclooxygenase inhibitory activity of some 1,3-dioxoisoindoline derivatives.
    Cizmeciolu M; Pabuguoglu V; Ballar P; Pabuççuoğlu A; Soyer Z
    Arzneimittelforschung; 2011; 61(3):186-90. PubMed ID: 21528644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR analysis of meclofenamic acid analogues as selective COX-2 inhibitors.
    Narsinghani T; Chaturvedi SC
    Bioorg Med Chem Lett; 2006 Jan; 16(2):461-8. PubMed ID: 16290292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAR studies of acidic dual γ-secretase/PPARγ modulators.
    Hieke M; Ness J; Steri R; Greiner C; Werz O; Schubert-Zsilavecz M; Weggen S; Zettl H
    Bioorg Med Chem; 2011 Sep; 19(18):5372-82. PubMed ID: 21873070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide.
    Sano H; Noguchi T; Tanatani A; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2005 May; 13(9):3079-91. PubMed ID: 15809144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 2-methyl-3-indolylacetic derivatives as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 without gastric damage.
    Perissutti E; Fiorino F; Renner C; Severino B; Roviezzo F; Sautebin L; Rossi A; Cirino G; Santagada V; Caliendo G
    J Med Chem; 2006 Dec; 49(26):7774-80. PubMed ID: 17181159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.